DPT Laboratories
Private Company
Funding information not available
Overview
DPT Laboratories is a long-established, U.S.-based CDMO with deep expertise in complex semi-solid and liquid drug delivery formats such as creams, ointments, gels, lotions, aerosols, and sprays. As a Viatris company, it offers a fully integrated service model from early-stage formulation development through clinical trial supplies and commercial manufacturing, emphasizing seamless technology transfers. Its core value proposition lies in its specialized technical capabilities in these dosage forms and its ability to guide products from development to commercialization within a single organization.
Technology Platform
Integrated CDMO platform specializing in the formulation, analytical development, and cGMP manufacturing of semi-solid and liquid dosage forms (creams, ointments, gels, lotions, aerosols, sprays, solutions, suspensions). Capabilities span pre-formulation, process development, clinical trial supply manufacturing, technology transfer, and commercial-scale production.
Opportunities
Risk Factors
Competitive Landscape
DPT competes in the specialized CDMO segment for semi-solids and liquids against other niche players and larger, diversified CDMOs that offer similar services. Its primary competitive advantages are its deep, 80+ year technical expertise in these specific dosage forms and its fully integrated, single-site service model from development to commercial manufacturing.